MFN2 and peripheral neuropathy: Charcot–Marie–Tooth disease type 2 A (CMT2A) disease is a peripheral neuropathy resulting from mutations in the mitochondrial fusion protein mitofusin-2 (MFN2), a large GTPase implicated in mitochondrial fusion and tethering with the endoplasmic reticulum [98].